17-46875165-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000290015.7(WNT9B):c.399G>T(p.Arg133=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0261 in 1,613,996 control chromosomes in the GnomAD database, including 655 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.033 ( 105 hom., cov: 33)
Exomes 𝑓: 0.025 ( 550 hom. )
Consequence
WNT9B
ENST00000290015.7 synonymous
ENST00000290015.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.982
Genes affected
WNT9B (HGNC:12779): (Wnt family member 9B) The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. Study of its expression in the teratocarcinoma cell line NT2 suggests that it may be implicated in the early process of neuronal differentiation of NT2 cells induced by retinoic acid. This gene is clustered with WNT3, another family member, in the chromosome 17q21 region. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 17-46875165-G-T is Benign according to our data. Variant chr17-46875165-G-T is described in ClinVar as [Benign]. Clinvar id is 1578578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.982 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.033 (5019/152320) while in subpopulation AFR AF= 0.0487 (2025/41580). AF 95% confidence interval is 0.0469. There are 105 homozygotes in gnomad4. There are 2326 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 105 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WNT9B | NM_003396.3 | c.399G>T | p.Arg133= | synonymous_variant | 3/4 | ENST00000290015.7 | NP_003387.1 | |
WNT9B | NM_001320458.2 | c.399G>T | p.Arg133= | synonymous_variant | 3/5 | NP_001307387.1 | ||
WNT9B | XM_011525178.3 | c.417G>T | p.Arg139= | synonymous_variant | 3/4 | XP_011523480.1 | ||
LRRC37A2 | XM_024450773.2 | c.4810-173891G>T | intron_variant | XP_024306541.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WNT9B | ENST00000290015.7 | c.399G>T | p.Arg133= | synonymous_variant | 3/4 | 1 | NM_003396.3 | ENSP00000290015 | P1 | |
WNT9B | ENST00000393461.2 | c.399G>T | p.Arg133= | synonymous_variant | 3/5 | 2 | ENSP00000377105 | |||
WNT9B | ENST00000575372.5 | downstream_gene_variant | 4 | ENSP00000458192 |
Frequencies
GnomAD3 genomes AF: 0.0329 AC: 5002AN: 152202Hom.: 103 Cov.: 33
GnomAD3 genomes
AF:
AC:
5002
AN:
152202
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0273 AC: 6838AN: 250610Hom.: 117 AF XY: 0.0276 AC XY: 3749AN XY: 135662
GnomAD3 exomes
AF:
AC:
6838
AN:
250610
Hom.:
AF XY:
AC XY:
3749
AN XY:
135662
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0254 AC: 37058AN: 1461676Hom.: 550 Cov.: 31 AF XY: 0.0258 AC XY: 18782AN XY: 727162
GnomAD4 exome
AF:
AC:
37058
AN:
1461676
Hom.:
Cov.:
31
AF XY:
AC XY:
18782
AN XY:
727162
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0330 AC: 5019AN: 152320Hom.: 105 Cov.: 33 AF XY: 0.0312 AC XY: 2326AN XY: 74476
GnomAD4 genome
AF:
AC:
5019
AN:
152320
Hom.:
Cov.:
33
AF XY:
AC XY:
2326
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
133
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at